Thomas Patrick Kelly Deciphera Pharmaceuticals, Inc. (DCPH) insider trading activity

Thomas Patrick Kelly is Chief Financial Officer of Deciphera Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of DCPH, which is worth approximately $0. The most recent transaction as insider was on Jun 11, 2024, when has been sold 72,029 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Thomas Patrick Kelly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 11 2024	SELL Sale (or disposition) back to the issuer	-	72,029 Reduced 62.9%	42,478 Common Stock
Jun 11 2024	SELL Disposition due to a tender of shares in a change of control transaction	-	42,478 Reduced 100.0%	0 Common Stock
Jun 11 2024	BUY Grant, award, or other acquisition	-	34,157 Added 22.98%	114,507 Common Stock
Feb 16 2024	SELL Open market or private sale	$47,016 $15.62 p/Share	3,010 Reduced 3.61%	80,350 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	17,275 Added 17.17%	83,360 Common Stock
Jan 16 2024	SELL Open market or private sale	$35,234 $14.47 p/Share	2,435 Reduced 3.55%	66,085 Common Stock
Dec 13 2023	SELL Open market or private sale	$42,913 $15.37 p/Share	2,792 Reduced 3.92%	68,520 Common Stock
Dec 12 2023	BUY Grant, award, or other acquisition	-	8,244 Added 10.36%	71,312 Common Stock
Oct 30 2023	SELL Open market or private sale	$27,838 $12.02 p/Share	2,316 Reduced 3.54%	63,068 Common Stock
Oct 28 2023	BUY Grant, award, or other acquisition	-	8,244 Added 11.2%	65,384 Common Stock
Jun 16 2023	SELL Open market or private sale	$23,832 $14.4 p/Share	1,655 Reduced 2.81%	57,140 Common Stock
Feb 16 2023	SELL Open market or private sale	$20,687 $15.1 p/Share	1,370 Reduced 2.28%	58,795 Common Stock
Feb 15 2023	BUY Grant, award, or other acquisition	-	16,488 Added 21.51%	60,165 Common Stock
Jan 17 2023	SELL Open market or private sale	$51,039 $21.24 p/Share	2,403 Reduced 5.21%	43,677 Common Stock
Jun 16 2022	SELL Open market or private sale	$19,006 $10.75 p/Share	1,768 Reduced 3.7%	46,080 Common Stock
Feb 16 2022	SELL Open market or private sale	$12,380 $9.05 p/Share	1,368 Reduced 2.78%	47,848 Common Stock
Jan 18 2022	BUY Grant, award, or other acquisition	-	20,500 Added 29.41%	49,216 Common Stock
Dec 15 2021	BUY Grant, award, or other acquisition	-	11,100 Added 27.88%	28,716 Common Stock
Feb 16 2021	SELL Open market or private sale	$25,608 $48.87 p/Share	524 Reduced 7.44%	6,516 Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	11,100 Added 38.65%	17,616 Common Stock

TPK

Thomas Patrick Kelly

Chief Financial Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DCPH shares.

Notify only if

Value

Insider Trading

Get notified when an Deciphera Pharmaceuticals, Inc. insider buys or sells DCPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Deciphera Pharmaceuticals, Inc.

Track Activities on DCPH

Account